Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND) (NCT04579120)

🧪 Interventions in This Study

• [11C]-Pittsburgh Compound B ([11C]PiB) (DRUG)
• F 18 AV-1451 (Flortaucipir) (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Washington University School of Medicine — St Louis, Missouri

📞 Contact the Study Coordinator

Phone: (314) 362-1558

Email: kelleyj@wustl.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Alzheimer Disease

• The Use of Memantine for Prevention of Alzheimer's Disease — Charlottesville, Virginia
• Investigation of Inflammation Using [C-11]-CS1P1 — St Louis, Missouri
• Sleep Disturbance and Emotion Regulation Brain Dysfunction as Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Dementia — Palo Alto, California
• A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study) — Gilbert, Arizona
• High Frequency Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease — Cambridge, Massachusetts
• A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease — Phoenix, Arizona

Explore by condition: All Alzheimer Disease clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.